September 2019 CHR in the News

In late July, Well+Good writer Kara Brown interviewed Dr. Gleicher for an article on menstrual periods. He urged women to see an OB/GYN when they notice irregularities in their periods, as these can be a sign of fertility-impacting issues like perimenopause or PCOS.

Dr. Gleicher was also quoted extensively in an August 5 article on Harper’s Bazaar, by Didi Gluck, titled “The Pill for Better Sex.” The article explains that there are two FDA-approved medications to help women with low sexual satisfaction–Addyi and Vyleesi–but they are not very effective and cause unpleasant and sometimes life-threatening side effects (nausea for up to two hours after a Vyleesi injection or fainting with Addyi). Dr. Gleicher presented the results of CHR’s recent study on DHEA’s positive effects on women’s sexual wellbeing and contrasted DHEA’s ease of use, lack of serious side effects and statistically significant improvements to the drawbacks of the two drugs.

VIVO for female sexual health is available from

This is a part of the September 2019 CHR VOICE.

Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned specialist in reproductive endocrinology, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.